Patrick Johan Hendrik Krol
Gründer bei Aescap Life Sciences
Profil
Patrick Johan Hendrik Krol is the founder of Aescap Life Sciences, which was founded in 2016.
He holds the title of Portfolio Manager at Aescap Life Sciences.
Mr. Krol was also the founder of UnitedHealthcare, Inc. Mr. Krol's current job(s) included being a Director at Shire International Licensing BV since 2004, a Director at F-star Biotechnology Ltd., a Co-Managing Director at Coöperatieve AESCAP Venture I UA, a Director at F-star Therapeutics Ltd., and a Managing Partner at Aescap Venture Management BV since 2005.
Mr. Krol's former job(s) include being a Director at F-Star Biotechnologische Forschungs-.
Und Entwicklungsges MBH, a Non-Executive Director at Aquapharm Biodiscovery Ltd., a Director at i-Optics BV, a Director at F-Star Therapeutics, Inc. (United States), a Director at Orphazyme A, a Healthcare Director at Fleishman-Hillard sro, a Director at F-Star Beta Ltd.
from 2014 to 2019, a Director at F-Star Delta Ltd., an Independent Director at F-star Therapeutics, Inc. from 2019 to 2022, a Member-Supervisory Board at to-BBB Holding BV, a Member-Supervisory Board at to-BBB technologies BV, and a Member-Supervisory Board at F-star Alpha Ltd.
from 2015 to 2019.
Mr. Krol's education history includes undergraduate studies at Hogeschool Utrecht, graduate studies at Business School Netherlands, and an MBA from Lemniscaat School of Management.
Aktive Positionen von Patrick Johan Hendrik Krol
Unternehmen | Position | Beginn |
---|---|---|
Aescap Venture Management BV
Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Private Equity Investor | 01.01.2005 |
Shire International Licensing BV
Shire International Licensing BV BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International Licensing BV is a Dutch biotechnology company. The company is based in Amsterdam, Netherlands. | Direktor/Vorstandsmitglied | 01.01.2004 |
F-star Biotechnology Ltd.
F-star Biotechnology Ltd. BiotechnologyHealth Technology F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Aescap Life Sciences | Gründer | 01.01.2016 |
Coöperatieve AESCAP Venture I UA | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Patrick Johan Hendrik Krol
Unternehmen | Position | Ende |
---|---|---|
F-STAR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 16.06.2022 |
F-Star Beta Ltd.
F-Star Beta Ltd. BiotechnologyHealth Technology F-Star Beta Ltd. is a biopharmaceutical company that focused in the development of oncology and immune-oncology products. The company was founded on October 14, 2014 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 01.05.2019 |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Direktor/Vorstandsmitglied | 01.05.2019 |
░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Patrick Johan Hendrik Krol
Hogeschool Utrecht | Undergraduate Degree |
Business School Netherlands | Graduate Degree |
Lemniscaat School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ORPHAZYME A/S | Health Technology |
Private Unternehmen | 18 |
---|---|
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Health Technology |
Aescap Life Sciences | Miscellaneous |
UnitedHealthcare, Inc.
UnitedHealthcare, Inc. Miscellaneous Commercial ServicesCommercial Services Part of UnitedHealth Group, Inc., UnitedHealthcare, Inc. is a health care company based in Edina, MN. UnitedHealthcare is dedicated to simplifying the health care experience, meeting consumer health and wellness needs, and sustaining trusted relationships with care providers. The company offers a full spectrum of health benefit programs for individuals, employers, and Medicare and Medicaid beneficiaries, and contracts directly with more than 1.5 million physicians and care professionals, and 7,000 hospitals and other care facilities nationwide. Additionally, UnitedHealthcare provides health benefits and delivers care to people through owned and operated health care facilities. The company also offers dual special needs plans that combine the benefits of both Medicare and Medicaid into one simple health plan. UnitedHealthcare is working with state and local health departments and the CDC to provide updates about coronavirus (COVID-19) and information on how to access care, resources, and support. The company was founded by Patrick Johan Hendrik Krol and Brian Thompson has been the CEO of the company since 2021. | Commercial Services |
Aescap Venture Management BV
Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Finance |
to-BBB Holding BV
to-BBB Holding BV Pharmaceuticals: GenericHealth Technology to-BBB Holding BV operated as a holding company with interest in providing central nervous system drug technology to the pharmaceutical and biotechnology industries. The firm developed medicines for the treatment of brain diseases. The company was headquartered in The Hague, the Netherlands. | Health Technology |
to-BBB technologies BV
to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Health Technology |
Aquapharm Biodiscovery Ltd.
Aquapharm Biodiscovery Ltd. Pharmaceuticals: MajorHealth Technology Aquapharm Biodiscovery Ltd. discovers and develops drugs. It develops products for application across the pharmaceutical, personal care and nutrition sectors. The company offers antibiotics, inflammation & dermatology, oxidative stress, high value ingredients and anti-oxidant ingredients. Aquapharm Biodiscovery was founded by Kathryn Fraser and Andrew Mearns Spragg on April 11, 2000 and is headquartered in Edinburgh, GB. | Health Technology |
i-Optics BV
i-Optics BV Medical SpecialtiesHealth Technology i-Optics BV develops and produces eye diagnosis and therapeutic solutions. Its lead product, the EasyScan, that provides non-mydriatic retina imaging camera for the diagnosis of diabetic retinopathy and macular degeneration. The firm engages in the development and marketing of retina and cornea imaging solutions. The company was founded by Michiel Mensink and is headquartered in The Hague, the Netherlands. | Health Technology |
F-Star Therapeutics, Inc. (United States)
F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA. | Health Technology |
Shire International Licensing BV
Shire International Licensing BV BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International Licensing BV is a Dutch biotechnology company. The company is based in Amsterdam, Netherlands. | Health Technology |
F-star Alpha Ltd.
F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Fleishman-Hillard sro
Fleishman-Hillard sro Miscellaneous Commercial ServicesCommercial Services Fleishman-Hillard sro is a Czech company that offers a wide selection of leather seats in different styles and designs. The private company is based in Prague, Czechia. The company also offers other home decor items such as rugs, furniture, and decorative pillows. | Commercial Services |
F-Star Beta Ltd.
F-Star Beta Ltd. BiotechnologyHealth Technology F-Star Beta Ltd. is a biopharmaceutical company that focused in the development of oncology and immune-oncology products. The company was founded on October 14, 2014 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
F-Star Delta Ltd.
F-Star Delta Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., F-Star Delta Ltd. develops antibody products to improve the treatment of serious diseases. The company is based in Cambridge, UK and was founded in 2016. | Health Technology |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
F-star Therapeutics, Inc.
F-star Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
F-star Biotechnology Ltd.
F-star Biotechnology Ltd. BiotechnologyHealth Technology F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
Coöperatieve AESCAP Venture I UA |